Patel Mahesh V. — SEC insider filings

SEC reporting owner CIK 1579872. 25 insider filings on record with FilingPulse; latest filed 2026-11-13.

Transaction summary — filings shown

Covers all 25 filings on record, filed 2020-12-08 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Lipocine Inc. (LPCN)Chief Executive Officer, Director2511 legs · 558,706 sh · $425,0242 legs · 58,500 sh · $88,38420

Insider filings — Patel Mahesh V.

FiledFormIssuerReported transactionsSource
2026-11-134Lipocine Inc. (LPCN)Purchase (P): 25,000 @ $1.58 · Purchase (P): 25,000 @ $1.60EDGAR
2026-06-304Lipocine Inc. (LPCN)Grant/award (A): 52,781 (derivative) @ $2.49EDGAR
2026-04-064Lipocine Inc. (LPCN)Purchase (P): 25,000 @ $2.03EDGAR
2026-04-024Lipocine Inc. (LPCN)Purchase (P): 25,000 @ $2.02EDGAR
2026-01-054Lipocine Inc. (LPCN)Grant/award (A): 25,000 (derivative) @ $8EDGAR
2025-12-194Lipocine Inc. (LPCN)Grant/award (A): 8,629 (derivative) @ $4.20EDGAR
2025-01-024/ALipocine Inc. (LPCN)Grant/award (A): 10,320 (derivative) @ $4.80EDGAR
2025-01-024Lipocine Inc. (LPCN)Grant/award (A): 16,371 (derivative) @ $4.86EDGAR
2024-12-304Lipocine Inc. (LPCN)Grant/award (A): 26,691 (derivative) @ $4.80EDGAR
2024-03-124Lipocine Inc. (LPCN)Grant/award (A): 4,893 @ $0EDGAR
2023-05-254Lipocine Inc. (LPCN)Purchase (P): 8,706 @ $5.03EDGAR
2023-03-244Lipocine Inc. (LPCN)Purchase (P): 150,000 @ $0.32EDGAR
2023-03-174Lipocine Inc. (LPCN)Purchase (P): 50,000 @ $0.33EDGAR
2023-01-044Lipocine Inc. (LPCN)Grant/award (A): 300,000 (derivative) @ $0.41EDGAR
2022-12-224Lipocine Inc. (LPCN)Grant/award (A): 112,500 (derivative) @ $0.41EDGAR
2022-11-144Lipocine Inc. (LPCN)Purchase (P): 75,000 @ $0.39EDGAR
2022-09-274Lipocine Inc. (LPCN)Purchase (P): 100,000 @ $0.41EDGAR
2022-05-164Lipocine Inc. (LPCN)Purchase (P): 50,000 @ $0.77EDGAR
2022-01-034Lipocine Inc. (LPCN)Grant/award (A): 287,500 (derivative) @ $1.09EDGAR
2021-12-084Lipocine Inc. (LPCN)Grant/award (A): 125,000 (derivative) @ $1.12EDGAR
2021-11-184Lipocine Inc. (LPCN)Purchase (P): 25,000 @ $1.09EDGAR
2021-01-044Lipocine Inc. (LPCN)Grant/award (A): 275,000 (derivative) @ $1.43EDGAR
2020-12-294Lipocine Inc. (LPCN)Other (J): 275,000 (derivative) @ $0EDGAR
2020-12-174Lipocine Inc. (LPCN)Option exercise (M): 45,000 @ $0 · Sale (S): 15,000 @ $1.35 · Grant/award (A): 375,000 (derivative) @ $1.37 · Option exercise (M): 45,000 (derivative) @ $0EDGAR
2020-12-084Lipocine Inc. (LPCN)Option exercise (M): 145,000 @ $0 · Sale (S): 43,500 @ $1.57 · Option exercise (M): 122,978 @ $0 · Option exercise (M): 145,000 (derivative) @ $0 · Option exercise (M): 122,978 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-11-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1579872 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs